{"abdominal pain upper": 2.17, "acute respiratory failure": 5.32, "asthenia": 2.34, "atrial fibrillation": 2.32, "balance disorder": 3.16, "blood potassium decreased": 6.44, "condition aggravated": 2.74, "dehydration": 2.52, "diplopia": 5.56, "dysphagia": 3.89, "fall": 6.38, "feeling abnormal": 2.28, "gait disturbance": 4.27, "gait inability": 3.29, "hospitalisation": 2.15, "hypoaesthesia oral": 10.27, "intentional product use issue": 4.79, "mobility decreased": 2.13, "muscle spasms": 2.04, "muscular weakness": 4.76, "myasthenic syndrome": 565.17, "nephrolithiasis": 3.36, "paraesthesia": 2.11, "paraesthesia oral": 15.22, "peripheral coldness": 4.33, "pneumonia": 2.49, "prescribed overdose": 7.7, "product dose omission issue": 5.96, "product substitution issue": 21.58, "pulmonary mass": 7.89, "rib fracture": 10.93, "speech disorder": 3.23, "therapeutic product effect decreased": 2.84, "therapeutic product effect incomplete": 9.3, "therapeutic response delayed": 91.13, "therapeutic response shortened": 47.3, "unevaluable event": 16.31, "urinary tract infection": 3.0, "weight decreased": 2.06}